70399-02-9

Basic information

• Product Name: 1-Bromo-4-(propane-2-sulfonyl)benzene
• Synonyms: 1-Bromo-4-(propane-2-sulfonyl)benzene;1-bromo-4-(isopropylsulfonyl)benzene
• CAS NO: 70399-02-9
• Molecular Formula: C₉H₁₁BrO₂S
• Molecular Weight: 263.15144
• Mol File: 70399-02-9.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 1-Bromo-4-(propane-2-sulfonyl)benzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Bromo-4-(propane-2-sulfonyl)benzene(70399-02-9)
• EPA Substance Registry System: 1-Bromo-4-(propane-2-sulfonyl)benzene(70399-02-9)

Safety Data

• Hazardous Substances Data: 70399-02-9(Hazardous Substances Data)

Usage

General Description

1-Bromo-4-(propane-2-sulfonyl)benzene, also known as 1-bromo-4-(2-propanesulfonyl)benzene, is a chemical compound with the molecular formula C9H11BrO2S. It is a derivative of benzene, with a bromine atom attached to the 1 position and a propane-2-sulfonyl group attached to the 4 position. 1-Bromo-4-(propane-2-sulfonyl)benzene is commonly used as a building block in organic synthesis, particularly in the production of pharmaceuticals and agrochemicals. It is a white to off-white solid with a slightly unpleasant odor and is soluble in organic solvents such as acetone, ethanol, and dichloromethane. 1-Bromo-4-(propane-2-sulfonyl)benzene is considered to be a potential environmental and human health hazard, and proper handling and disposal procedures should be followed when working with this compound.

Upstream product

• 75-30-9 2-iodo-propane 
• 106-53-6 para-bromobenzenethiol 
• 106-37-6 1.4-dibromobenzene 
• 106-40-1 4-bromo-aniline 
• 26732-20-7 4-bromo-(ethylsulfonyl)benzene 
• 70398-89-9 1-bromo-4-(1-methylethylthio)benzene 

Downstream Products

• 850567-98-5 4-(isopropylsulfonyl)phenylboronic acid 

Relevant articles and documents

Visible-light-driven electron donor-acceptor complex induced sulfonylation of diazonium salts with sulfinates

This work reports an efficient sulfonylation reaction enabled by a visible-light-induced radical coupling reaction between phenyl/heterocyclic diazonium salts and sulfinates. Mechanistic experiments disclosed the formation of a versatile electron donor-acceptor (EDA) complex. This transformation is characterized by an easy operational procedure under mild conditions which avoids transition metals, ligands, catalysts, and oxidants.

DI-SUBSTITUTED PYRAZOLE COMPOUNDS FOR THE TREATMENT OF DISEASES

Provided herein are compounds, pharmaceutical compositions comprising the compounds, and methods of using the compounds and compositions in treating a condition, disease, or disorder associated with abnormal activation of the SREBP pathway, including meta